Lower courts “relied at every stage on patently unreliable witnesses and studies,” the ACLU said in its amicus brief.
By Chris Walker, TRUTHOUT
An amicus brief — or “friend of the court” petition — submitted to the U.S. Supreme Court by the American Civil Liberties Union (ACLU) urges justices of the High Court to reject lower court orders that have sought to severely curtail access to abortion medication known as mifepristone.

The drug is used in a majority of abortions across the country, and is currently approved for up to 10 weeks of pregnancy. Deregulation of its use during the COVID-19 pandemic (and following the Court’s overturn of Roe v. Wade in June 2022) allowed for the drug to be more widely available, permitting doctors to prescribe it through telemedicine and letting it be sent to patients through the mail.
However, actions by a far right federal judge in Texas, as well as affirmation of parts of that judgment from a conservative appellate court, now threaten access to the drug for those who want or need it. Both opinions, the ACLU writes in its brief to the Supreme Court, were based on “junk science.”
Recent Posts
Senators Launch Bipartisan Bid to Block Trump War on Venezuela
October 18, 2025
Take Action Now “Congress has not authorized military force against Venezuela,” said Sen. Adam Schiff. “And we must assert our authority to stop the…
Democrats Have Let Republicans Become The “Peace” Party
October 17, 2025
Take Action Now The massive disconnect between the Democratic Party’s leadership and its base is sure to have ramifications far beyond last year’s…
‘Textbook Authoritarianism’: Trump Aims IRS Criminal Division At Left-Leaning Groups, Donors
October 16, 2025
Take Action Now Reporting by the Wall Street Journal indicates the active “weaponization” of the agency to target the far-right president’s political…
Trump Knesset Speech Displays Complete U.S. Backing Of Israel
October 15, 2025
Take Action Now Trump stirred controversy in several off-script moments in his address to the Israeli Knesset, including spotlighting a top…